title: Regenerative medicine in China: demands, capacity, and regulation.
abstract: Regenerative medicine (RM) is an emerging interdisciplinary field of research. Its clinical application focuses on the repair, replacement, and regeneration of cells, tissues, and organs by approaches including cell reprogramming, stem cell transplantation, tissue engineering, activating factors, and clone treatment. RM has become a hot point of research in China and other countries. China's main and local governments have attached great importance to RM and given strong support in relevant policies and funding. About 3.5 billion RMB has been invested in this field. Since 1999, China has established about 30 RM centers and cooperates with many advanced countries in RM research and benefits from their cooperation. However, China needs to develop standards, regulations, and management practices suitable for the healthy development of RM. In this review, we focus on its great demand, capacity, and relative regulations.
authors: College of Life Sciences, Medical College of PLA, General Hospital of PLA, Beijing, 100853 People's Republic of China ; The Key Laboratory of Trauma Treatment & Tissue Repair of Tropical Area, PLA, Guangzhou, 510010 People's Republic of China.
authors: Biao
authors: B
authors: Cheng
authors: Ruijin Hospital, Shanghai Jiao Tong University, Shanghai, 200025 People's Republic of China.
authors: Shuliang
authors: S
authors: Lu
authors: College of Life Sciences, Medical College of PLA, General Hospital of PLA, Beijing, 100853 People's Republic of China ; Chinese Academy of Engineering (Division of Medical and Health), College of Life Sciences, Medical College of PLA, General Hospital of PLA, 28 Fu Xian Road, Beijing, 100853 People's Republic of China.
authors: Xiaobing
authors: X
authors: Fu
keywords: China; Regenerative medicine; Stem cell; Tissue engineering